Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Matthew Halpert"'
Autor:
Matthew Halpert, Chris Verrico, Shonda Wesson, Vanaja Konduri, Colby Hofferek, Jonathan Vazquez-Perez, Emek Blair, Kenneth Dunner, Pedram Salimpour, William K Decker
Publikováno v:
The Journal of Immunology. 204:67.11-67.11
Hemp-derived cannabidiol (CBD) is the major non-psychoactive component of cannabis and has been promoted as a potential treatment for a wide variety of disparate inflammatory conditions. Here we evaluated CBD for its ability to modulate the productio
Autor:
Matthew Halpert, Jonathan Vasquez-Perez, Vanaja Konduri, Yunyu Chen, Dan Liang, Jonathan M. Levitt, William K. Decker
Publikováno v:
The Journal of Immunology. 200:109.11-109.11
CTLA-4, the target of the blockbuster cancer immunotherapeutic ipilimumab, is the best characterized of the T-cell immune checkpoints. In contrast to T-cell expressed CTLA-4, almost nothing is known about CTLA-4 expression or function in non-lymphoid
Autor:
Vanaja Konduri, Dan (Vivian) Liang, Matthew Halpert, Jonathan Levitt, Peter Hotez, Kathryn Jones, William Decker
Publikováno v:
The Journal of Immunology. 194:145.14-145.14
Chagas Disease, caused by infection with the protozoan parasite Trypanosoma cruzi, is a leading cause of heart disease and sudden cardiac death in Latin America, disproportionately affecting people living in resource-poor areas. Approved treatment is
Autor:
Dan Liang, Matthew Halpert, Vanaja Konduri, Yunyu Chen, Doyeun Kim, Sunghoon Kim, Jonathan Levitt, William Decker
Publikováno v:
The Journal of Immunology. 194:128.9-128.9
Of professional antigen presenting cells, only the dendritic cells (DC) are regarded as initiators of adaptive immune responses. Previously we identified a Th1 polarizing phenotype from DCs loaded with overlapping (homologous) MHC class I and II dete
Autor:
Matthew Halpert, Dan Liang, Vanaja Konduri, Robia Pautler, Sherry Klumpp, Ratan Bhardwaj, Jonathan Levitt, William Decker
Publikováno v:
The Journal of Immunology. 194:128.13-128.13
Attempts to treat cancer by vaccine immunotherapy have produced unsatisfactory results in part due to an inability to generate effective TH1 immunity. Here we demonstrate the existence of an elegant TH1 regulatory mechanism based upon release of the
Autor:
Matthew Halpert, Vanaja Konduri, Dan Liang, Yunyu Chen, James Wing, Silke Paust, Jonathan Levitt, William Decker
Publikováno v:
The Journal of Immunology. 194:128.11-128.11
Cytotoxic T-Lymphocyte Associated protein-4 (CTLA-4), the target of the blockbuster cancer immunotherapeutic ipilimumab, is a regulatory molecule of the B7 superfamily known to inhibit T-cell responses by a variety of different mechanisms. While CTLA
Autor:
Matthew Halpert, Julienne Cloud-Carstens, Matthew Collinson-Pautz, Dan Liang, Vanaja Konduri, Sherry Klump, Ratan Bhardwaj, Michael Berens, Robia Paulter, David Spencer, Jonathan Levitt, William Decker
Publikováno v:
The Journal of Immunology. 190:47.12-47.12
The current understanding of TH1 polarization and the central role dendritic cells (DC) play in skewing such a response engender hope that DC-based vaccines may ultimately be capable of promoting therapeutic efficacy against recalcitrant pathogens an
Publikováno v:
The Journal of Immunology. 186:102.24-102.24
TLT2 is one of four receptors conserved between mouse and human within the TREM locus, and is expressed on B cells, macrophages, and neutrophils. TLT2 ligation on murine macrophages induces the production of chemokines and growth factors, as evidence